Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yoko Yanagawa

Epigallocatechin Gallate Suppresses Expression of Receptor Activator of NF- B Ligand (RANKL) in Staphylococcus Aureus Infection in Osteoblast-Like NRG Cells

Journal of Medical Microbiology

Medicine

Microbiology

2007

English

Related publications

Embelin Suppresses Osteoclastogenesis Induced by Receptor Activator of NF- B Ligand and Tumor Cells in Vitro Through Inhibition of the NF- B Cell Signaling Pathway

Molecular Cancer Research

English

Sphingosine 1-Phosphate (S1p)/S1p Receptor 1 Signaling Regulates Receptor Activator of NF-κB Ligand (RANKL) Expression in Rheumatoid Arthritis

Biochemical and Biophysical Research Communications

English

Staphylococcus Aureus Peptidoglycan Is a Toll-Like Receptor 2 Activator: A Reevaluation

Infection and Immunity

English

Transforming Growth Factor-Β Induces Expression of Receptor Activator of NF-κB Ligand in Vascular Endothelial Cells Derived From Bone

Journal of Biological Chemistry

English

Role of P53 and NF-κB in Epigallocatechin-3-Gallate-Induced Apoptosis of LNCaP Cells

English

Epigallocatechin-3-Gallate Suppresses IGF-I-Induced Lipogenesis and Cytokine Expression in SZ95 Sebocytes

Journal of Investigative Dermatology

English

Receptor Activator of NF- B Ligand (RANKL) Activates TAK1 Mitogen-Activated Protein Kinase Kinase Kinase Through a Signaling Complex Containing RANK, TAB2, and TRAF6

Molecular and Cellular Biology

Cell Biology

Molecular Biology

2002

English

Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Directly Modulates the Gene Expression Profile of RANK-positive Saos-2 Human Osteosarcoma Cells

English

Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)/RANK Signaling Promotes Cancer-Related Inflammation Through M2 Macrophages

Experimental Dermatology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yoko Yanagawa

Epigallocatechin Gallate Suppresses Expression of Receptor Activator of NF- B Ligand (RANKL) in Staphylococcus Aureus Infection in Osteoblast-Like NRG Cells

Related publications

Embelin Suppresses Osteoclastogenesis Induced by Receptor Activator of NF- B Ligand and Tumor Cells in Vitro Through Inhibition of the NF- B Cell Signaling Pathway

Sphingosine 1-Phosphate (S1p)/S1p Receptor 1 Signaling Regulates Receptor Activator of NF-κB Ligand (RANKL) Expression in Rheumatoid Arthritis

Staphylococcus Aureus Peptidoglycan Is a Toll-Like Receptor 2 Activator: A Reevaluation

Transforming Growth Factor-Β Induces Expression of Receptor Activator of NF-κB Ligand in Vascular Endothelial Cells Derived From Bone

Role of P53 and NF-κB in Epigallocatechin-3-Gallate-Induced Apoptosis of LNCaP Cells

Epigallocatechin-3-Gallate Suppresses IGF-I-Induced Lipogenesis and Cytokine Expression in SZ95 Sebocytes

Receptor Activator of NF- B Ligand (RANKL) Activates TAK1 Mitogen-Activated Protein Kinase Kinase Kinase Through a Signaling Complex Containing RANK, TAB2, and TRAF6

Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Directly Modulates the Gene Expression Profile of RANK-positive Saos-2 Human Osteosarcoma Cells

Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)/RANK Signaling Promotes Cancer-Related Inflammation Through M2 Macrophages